Maintenance therapy versus episodic therapy with infliximab for Crohn's disease

被引：2

作者：

Ghosh, Subrata ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Gastroenterol Sect, London W12 0NN, England

来源：

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2004年 / 1卷 / 02期

关键词：

antibody response; Crohn's disease; episodic therapy; infliximab; maintenance therapy;

D O I：

10.1038/ncpgasthep0039

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：80 / 81

页数：2

共 6 条

[1] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].

Baert, F ;

Noman, M ;

Vermeire, S ;

Van Assche, G ;

D'Haens, G ;

Carbonez, A ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608

[2] Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial [J].

Farrell, RJ ;

Alsahli, M ;

Jeen, YT ;

Falchuk, KR ;

Peppercorn, MA ;

Michetti, P .

GASTROENTEROLOGY, 2003, 124 (04) :917-924

[3] Incidence and Importance of Antibody Responses to Infliximab After Maintenance or Episodic Treatment in Crohn's Disease [J].

Hanauer, Stephen B. ;

Wagner, Carrie L. ;

Bala, Mohan ;

Mayer, Lloyd ;

Travers, Suzanne ;

Diamond, Robert H. ;

Olson, Allan ;

Bao, Warren ;

Rutgeerts, Paul .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (07) :542-553

[4] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[5] Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease [J].

Rutgeerts, P ;

Feagan, BG ;

Lichtenstein, GR ;

Mayer, LF ;

Schreiber, S ;

Colombel, JF ;

Rachmilewitz, D ;

Wolf, DC ;

Olson, A ;

Bao, WH ;

Hanauer, SB .

GASTROENTEROLOGY, 2004, 126 (02) :402-413

[6] Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunize [J].

Sandborn, WJ .

GASTROENTEROLOGY, 2003, 124 (04) :1140-1145

← 1 →